Navigation Links
Eularis Releases Update of Its Comprehensive Report on Maximizing the Bottom Line in Pharmaceutical Marketing
Date:10/30/2007

NEW YORK and LONDON, Oct. 30 /PRNewswire/ -- Eularis is announcing the release of an update to its report, "Ensuring Profitable Return-on-Investment (ROI) in Pharmaceutical Marketing: Using Analytics and Metrics to Improve the Bottom Line." Originally offered in February 2007, the comprehensive report has been revised to provide pharmaceutical marketers with a competitive edge and the latest research information.

*(LOGO 72dpi: Send2Press.com/mediaboom/07-0924-Eularis_72dpi.jpg)

"The pharmaceutical environment is turbulent, and what used to work to create an industry-wide growth of 20 percent, no longer does," said the author of the report, Dr. Andree K. Bates, president of Eularis. "As market growth slows, the bottom line return for brands is under increased scrutiny, and every marketing dollar must count."

Eularis identified a common problem faced by pharmaceutical companies -- how to know which activities impact market share and by how much. The company assembled a group of world-leading mathematicians in the predictive analytics field, as well as thought leaders, to find the solution.

This report, in turn, analyzes how top pharmaceutical marketing leaders are handling pressing marketing return issues, and offers new ideas to apply. The detailed research addresses issues such as: ROI basics; practical skills marketers need for measuring marketing effectiveness; tools and best practices that make a difference; measurement principles that drive successful marketing measurement; how to propel strategy, growth, and bottom line return; plus an array of case studies.

The report also explains what real people did to measure, improve, and prove bottom line return. It uncovers practices to predict how and where pharmaceutical marketing and sales investments will yield the highest market share and market share price. Readers will benefit from the step-by-step guidelines on successfully implementing approaches for real and measurable results available only in this report.

Dr. Andree Bates, president of Eularis, has gained wide recognition within the international pharmaceutical industry for her expertise in marketing return analysis and is the author of this must-have report for all pharmaceutical industry marketers.

To purchase this report, visit: http://www.pharmamarketingroi.com.

About Eularis

Eularis provides sophisticated pharmaceutical analytics that provide data-driven insight into the financial impact of corporate and marketing decisions. Unlike traditional analytics approaches which are lengthy and whose reliance on historical or analogue data reduces their accuracy, Eularis' proprietary 94.8 Analytics Process is based on the current market situation. This proven approach helps pharmaceutical marketing teams to quickly plan, measure, validate, and optimize their sales and marketing performance. Eularis offers pre-launch analytics, marketing mix modeling (both professional and consumer), portfolio optimization, sales force effectiveness, managed care analytics, and patient compliance solutions. Co-headquartered in London and New York City, the company has developed significant experience in the global pharmaceutical market through client engagements with AstraZeneca, GlaxoSmithKline, Merck, Pfizer and many others.

For more information about Eularis, visit http://www.eularis.com.

This release was issued on behalf of the above organization by Send2Press(R), a unit of Neotrope(R). http://www.Send2Press.com


'/>"/>
SOURCE Eularis
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Sweet corn releases antioxidants on cooking
2. An International Growth Standard For Childs Releases By WHO
3. The National Governors Association Releases Guidelines For Outbreak Of Bird Flu
4. Eli Lilly Releases Digital Insulin Pen
5. WHO Updates Outdated Pediatric Growth Charts
6. High -tech Mitochondrial DNA Sequencing Tool Updated
7. Updated Sleep Apnea Screening Recommended for Commercial Drivers
8. Warning on Avastin Updated
9. NanoSensors Provides Update on Its Biosensor to Detect E.coli and Salmonella
10. A Comprehensive CD-ROM On HIV/AIDS Released By Center for HIV Information
11. ‘Comprehensive Sex Education’ Favored Against ‘Abstinence-Only’ Progams
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... ... 05, 2016 , ... The Lymphoma Research Foundation (LRF) – ... serving the lymphoma community through a comprehensive series of education programs, outreach initiatives ... Tasting Event at the La Gorce Country Club in Miami Beach on March ...
(Date:2/5/2016)... (PRWEB) , ... February 05, 2016 , ... Give ... allow users to search for and donate to Give To Cure’s campaign that is ... app that lets users make and share payments through a smart device. In 2015 ...
(Date:2/5/2016)... ... 2016 , ... Stuart Bentkover, MD, FACS is thrilled to announce ... most effective tattoo removal today, Dr. Bentkover is the only doctor in Central Massachusetts ... PicoSure has been approved by the Food and Drug Administration (FDA) as a safe ...
(Date:2/5/2016)... ... February 05, 2016 , ... California Mobile Kitchens ... debut of their latest mobile kitchen model, featuring customizable stainless steel interiors and ... commercial kitchens for use anywhere in the U.S. Many of their units can ...
(Date:2/5/2016)... (PRWEB) , ... February 05, 2016 , ... Susan ... Medicare San Luis Obispo users can expect to see in 2016. To view the ... most significant changes will directly impact many San Luis Obispo seniors who rely on ...
Breaking Medicine News(10 mins):
(Date:2/4/2016)... , Feb. 4, 2016 For hospitals ... or those already participating in the program, the Health ... referred to as the , Mega-Guidance , could have ... guidance is published in September 2016. Essential ... and Service Marketing , summarizes the Mega-Guidance,s key proposed ...
(Date:2/4/2016)... -- Worldwide Radiology Oncology surgical robot markets are ... systems provide a way to improve traditional open ... systems pinpoint the delivery of radiation precisely, eliminating ... problem previously, limiting the quantity of radiation that ... far beyond what has been available, promising a ...
(Date:2/4/2016)... , Feb. 4, 2016 Wegener ... Global Markets Direct,s, ,Wegener Polyangiitis - Pipeline ... Wegener Polyangiitis,s therapeutic pipeline. This report provides ... Polyangiitis, complete with comparative analysis at various stages, ... (MoA), route of administration (RoA) and molecule type, ...
Breaking Medicine Technology: